Why is reshape Lifesciences (RSLs) stock up 136% today?

Reshape Lifesciences ( RSLS) stock is soaring alongside SEC filings. The company is withdrawing a filing connected to a public stock offering. However, it’s not withdrawing the stock offering itself.

What is reshape Lifesciences?

ReShape Lifesciences™ is America's premier weight loss and metabolic health-solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease.

Why is reshape Lifesciences stock rocketing higher on Friday?

Reshape Lifesciences (NASDAQ: RSLS) stock is rocketing higher on Friday as a filing mixup shines a light on the company’s shares. According to a filing with the U.S. Securities and Exchange Commission (SEC), Reshape Lifesciences is seeking the withdrawal of two filings made with the agency on Thursday.

Will reshape Lifesciences delay its earnings release & conference call?

SAN CLEMENTE, Calif., March 28, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that it will delay its year ended December 31, 2022 earnings release and conference call, previously scheduled for 8:00 am ET on March 29, 2022.